• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症合并缺血性脑卒中患者的凝血障碍和栓塞信号。

Coagulopathy and embolic signal in cancer patients with ischemic stroke.

机构信息

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Ann Neurol. 2010 Aug;68(2):213-9. doi: 10.1002/ana.22050.

DOI:10.1002/ana.22050
PMID:20695014
Abstract

OBJECTIVE

It has been reported that embolic signal (ES) detected by transcranial Doppler (TCD) has clinical significance, especially in patients with recent stroke attributable to arterial or cardiac embolism. Therefore, we conducted this study to determine whether the prevalence of ES is high in ischemic stroke patients with cancer and related to hypercoagulopathy.

METHODS

We prospectively studied cancer patients with acute ischemic stroke within the middle cerebral artery (MCA) distribution on diffusion-weighted imaging. Conventional stroke mechanisms (CSMs) were determined using cardiologic and vascular studies. Additionally, the coagulation status was assessed based on the serum D-dimer levels, and TCD monitoring was performed on both MCAs for 30 minutes to detect ES. Clinical features including vascular risk factors, characteristics of ischemic stroke, and cancer and laboratory findings associated with the presence of ES were evaluated.

RESULTS

A total of 74 patients were finally included in this study. ES was more commonly observed in patients without CSMs (22 of 38 patients, 57.9%) than in those with CSMs (12 of 36 patients, 33.3%) (p = 0.034). Moreover, ES was more commonly detected in patients with high D-dimer levels (p < 0.001), and D-dimer levels were significantly correlated with the number of ESs in patients without CSMs (r = 0.732, p < 0.001), but were poorly correlated in patients with CSMs (r = 0.152, p = 0.375). Higher levels of D-dimer (odds ratio [OR], 1.082 per 1 microg/ml increase; 95% confidence interval [CI], 1.014-1.154) and adenocarcinoma (OR, 3.829; 95% CI, 1.23-13.052) were independently associated with the presence of ES. The use of anticoagulants dramatically decreased the D-dimer levels.

INTERPRETATION

A high prevalence of ES was observed in cancer patients with ischemic stroke, especially in those without CSMs. Elevated D-dimer levels were independently associated with ES, and decreased dramatically with the use of anticoagulants. ANN NEUROL 2010;68:213-219.

摘要

目的

据报道,经颅多普勒(TCD)检测到的栓子信号(ES)具有临床意义,尤其是在归因于动脉或心源性栓塞的近期卒中患者中。因此,我们进行了这项研究,以确定癌症合并缺血性卒中患者中 ES 的发生率是否较高,以及 ES 是否与高凝状态相关。

方法

我们前瞻性地研究了弥散加权成像显示大脑中动脉(MCA)分布区急性缺血性卒中的癌症患者。通过心脏和血管研究确定常规卒中机制(CSM)。此外,基于血清 D-二聚体水平评估凝血状态,并对双侧 MCA 进行 30 分钟的 TCD 监测以检测 ES。评估了与 ES 存在相关的临床特征,包括血管危险因素、缺血性卒中特征、癌症和实验室发现。

结果

本研究最终纳入了 74 例患者。无 CSM 的患者(38 例患者中有 22 例,57.9%)比有 CSM 的患者(36 例患者中有 12 例,33.3%)更常出现 ES(p=0.034)。此外,ES 在 D-二聚体水平较高的患者中更常见(p<0.001),并且 D-二聚体水平与无 CSM 患者的 ES 数量显著相关(r=0.732,p<0.001),但与有 CSM 的患者相关性差(r=0.152,p=0.375)。较高的 D-二聚体水平(比值比[OR],每增加 1μg/ml 增加 1.082;95%置信区间[CI],1.014-1.154)和腺癌(OR,3.829;95%CI,1.23-13.052)与 ES 的存在独立相关。抗凝治疗可显著降低 D-二聚体水平。

结论

在缺血性卒中的癌症患者中,ES 的高发生率很常见,尤其是在无 CSM 的患者中。升高的 D-二聚体水平与 ES 独立相关,且在使用抗凝剂后可显著降低。ANN NEUROL 2010;68:213-219。

相似文献

1
Coagulopathy and embolic signal in cancer patients with ischemic stroke.癌症合并缺血性脑卒中患者的凝血障碍和栓塞信号。
Ann Neurol. 2010 Aug;68(2):213-9. doi: 10.1002/ana.22050.
2
Prevalence of embolic signals in acute coronary syndromes.急性冠状动脉综合征中的栓塞信号的发生率。
Stroke. 2010 Feb;41(2):261-6. doi: 10.1161/STROKEAHA.109.566380. Epub 2009 Dec 31.
3
Stroke risk and prognostic factors of asymptomatic middle cerebral artery atherosclerotic stenosis.无症状大脑中动脉粥样硬化性狭窄的卒中风险及预测因素。
J Neurol Sci. 2011 Feb 15;301(1-2):63-5. doi: 10.1016/j.jns.2010.10.029. Epub 2010 Nov 20.
4
Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea.癌症患者伴发和不伴发传统机制的缺血性脑卒中:韩国多中心研究。
Stroke. 2010 Apr;41(4):798-801. doi: 10.1161/STROKEAHA.109.571356. Epub 2010 Feb 11.
5
Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease.有症状与无症状大脑中动脉疾病患者的卒中复发情况。
Neurology. 2005 Sep 27;65(6):859-64. doi: 10.1212/01.wnl.0000175983.76110.59.
6
Microembolic signals within 24 hours of stroke onset and diffusion-weighted MRI abnormalities.中风发作24小时内的微栓塞信号及弥散加权磁共振成像异常。
Cerebrovasc Dis. 2007;23(4):282-8. doi: 10.1159/000098328. Epub 2006 Dec 29.
7
Relationship of endocarditis, disseminated intravascular coagulation, and embolic signals in cancer with stroke.癌症患者的心内膜炎、弥散性血管内凝血及栓塞信号与中风的关系。
Ann Neurol. 2012 Jan;71(1):146. doi: 10.1002/ana.22306.
8
Timing of clinically significant microembolism after carotid endarterectomy.颈动脉内膜切除术后具有临床意义的微栓塞发生时间。
Cerebrovasc Dis. 2007;23(5-6):362-7. doi: 10.1159/000099135. Epub 2007 Jan 30.
9
Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study.大脑中动脉狭窄患者急性脑梗死的机制:一项弥散加权成像和微栓子监测研究
Ann Neurol. 2002 Jul;52(1):74-81. doi: 10.1002/ana.10250.
10
The relationship between neurological worsening and lesion patterns in patients with acute middle cerebral artery stenosis.急性大脑中动脉狭窄患者神经恶化与病变模式的关系。
Cerebrovasc Dis. 2013;35(3):268-75. doi: 10.1159/000348313. Epub 2013 Mar 26.

引用本文的文献

1
Hidden Cancer as the Cause of an Ischemic Stroke: A Case Report.隐匿性癌症作为缺血性卒中的病因:一例报告
Cureus. 2025 Apr 10;17(4):e82001. doi: 10.7759/cureus.82001. eCollection 2025 Apr.
2
Cardio-cerebral infarction: a narrative review of pathophysiology, treatment challenges, and prognostic implications.心脑梗死:病理生理学、治疗挑战及预后意义的叙述性综述
Front Cardiovasc Med. 2025 Mar 25;12:1507665. doi: 10.3389/fcvm.2025.1507665. eCollection 2025.
3
Screening tools for malignancy in patients with cryptogenic stroke: Systematic review.
隐源性卒中患者恶性肿瘤筛查工具:系统评价
Eur Stroke J. 2025 Feb 26:23969873241310760. doi: 10.1177/23969873241310760.
4
Microembolic signal detection in acute ischemic stroke: Clinical relevance and impact on treatment individualization-A narrative review.急性缺血性卒中中的微栓塞信号检测:临床相关性及对治疗个体化的影响——一篇叙述性综述
Eur J Neurol. 2025 Jan;32(1):e16584. doi: 10.1111/ene.16584.
5
Epidemiology, Pathophysiology, and Management of Cancer-Associated Ischemic Stroke.癌症相关性缺血性卒中的流行病学、病理生理学及管理
Cancers (Basel). 2024 Nov 29;16(23):4016. doi: 10.3390/cancers16234016.
6
Direct Oral Anticoagulants vs. Heparin for Cancer-Related Stroke: Augmented Meta-Analysis.直接口服抗凝剂与肝素用于癌症相关性卒中的比较:增强型荟萃分析
medRxiv. 2024 Nov 15:2024.11.14.24317340. doi: 10.1101/2024.11.14.24317340.
7
Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2.癌症相关静脉血栓栓塞患者缺血性卒中的发病率及危险因素:来自静脉血栓栓塞患者当代管理与结局登记研究-2
Res Pract Thromb Haemost. 2024 Oct 30;8(8):102617. doi: 10.1016/j.rpth.2024.102617. eCollection 2024 Nov.
8
Association of Transcranial Doppler Microembolic Signal With Short-Term Mortality in Acute Ischemic Stroke and Active Cancer.经颅多普勒微栓子信号与急性缺血性卒中和活动性癌症的短期死亡率的相关性。
J Am Heart Assoc. 2024 Aug 6;13(15):e033634. doi: 10.1161/JAHA.123.033634. Epub 2024 Jul 31.
9
Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC.不明来源栓塞性脑卒中:ESC 卒中委员会、欧洲心血管影像协会和 ESC 欧洲心律协会的临床共识声明。
Eur Heart J. 2024 May 21;45(19):1701-1715. doi: 10.1093/eurheartj/ehae150.
10
Cancer and arterial thrombosis: therapeutic options.癌症与动脉血栓形成:治疗选择
Res Pract Thromb Haemost. 2024 Mar 27;8(3):102393. doi: 10.1016/j.rpth.2024.102393. eCollection 2024 Mar.